Investor Relations

Company Overview

Based in Singapore, we are a biotech company focusing on chronic wound care and cosmeceutical products, leveraging natural materials and biomedical research. Our MEDIFLY bio-dressing, a leader in Maggot Debridement Therapy, alongside pipeline products like bullfrog collagen dressings and medical leech products, underscore our commitment to innovation. Facing risks of development and regulatory approval, we aim to address all wound healing stages. With products already in Singapore and Hong Kong, our future plans include expansion to Southeast Asia, the Middle East, and China, driven by aging demographics and rising chronic conditions.

Cuprina Homepage Lab

Latest Quarterly Results

For detailed financial information, please refer to regular filings.

Latest Presentation

July 29, 2024

July 2024 Investor Presentation

View Presentation

Event Calendar

View All Events

Email Alerts

Investor Relations Email Alerts

You may automatically receive company information by email. To choose your options for email notification, please enter your email address below, select one or more alerts and click 'submit'.

To change your email options at any time, re-enter your email address, make your new alert selections and click 'submit'.

All fields marked with an asterix are required.

Subscribe to Email Alerts

Unsubscribe from Email Alerts

By entering your email address below, you will no longer receive email alerts for any of the subscriptions listed above. If you do unsubscribe from email alerts, you can subscribe again any time by using the sign up process above.

Email Alerts*